ASTECNSEAstec LifeSciences Limited· Fertilizers & AgrochemicalsHighNeutral
Announced Fri, 30 Jan, 2026 · 17:47 IST

Astec Q3 FY26: revenue up 33% YoY but net loss of Rs 15.7 Cr continues

Revenue Growth 20pctPat NegativeExceptional ItemResults View source PDFExplain this filing

ASTEC · price

Loading chart…

▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.

Price reactionminutes from the announcement price · days from the prior close
+2.8%Reaction day
₹572.05
prior close
₹571.00
announcement price
After-mkt
timing
Nifty Microcap 250market · in no size index; the smallest one is used-1.3%+4.0% vs market
Pesticides & Agrochemicals peers, median of 26sector-0.3%+3.1% vs sector

On the reaction day the stock moved 4.0 pts more than Nifty Microcap 250 and 3.1 pts more than its Pesticides & Agrochemicals peers, over the same two closes: a difference in percentage points, not a measure of what the filing did.

Minutes after the announcementfrom the announcement price · no benchmark
Stock
5m
+1.1
10m
-0.2
15m
+0.6
30m
+1.4
Sessions after the filingfrom the prior close
StockMarketvs marketSectorvs sector
Reaction day
+2.8-1.3+4.0-0.3+3.1
Next day
+4.0+2.4+1.5+1.0+2.9
2d
+6.2+3.8+2.4+1.9+4.2
3d
+13.3+2.7+10.5+2.3+11.0
4d
+12.9+1.9+11.0+1.5+11.5
5d
+10.8+4.6+6.3+2.9+7.9
1w
+7.9+5.1+2.9+3.9+4.0
15d
+9.9+2.1+7.8-1.7+11.6
1m
+9.3-2.1+11.4-6.3+15.7
2m
-5.6-6.4+0.8-13.3+7.7
3m
+25.9+9.5+16.3-3.9+29.7
UpDownMarket · Nifty Microcap 250Sector · Pesticides & Agrochemicals peers, median of 26Pending

Minute windows have no benchmark: there is no intraday index history to compare against.

AI summary

Q3 FY26 standalone revenue rose 33% YoY to Rs 124.7 Cr from Rs 93.9 Cr. Net loss narrowed to Rs 15.7 Cr from Rs 40.4 Cr in Q3 FY25. For 9M FY26, revenue grew 11% to Rs 289.5 Cr with a Rs 73.2 Cr loss versus Rs 118.7 Cr last year. Loss includes Rs 2.1 Cr exceptional item from new Labour Codes. CFO Mugdha Khare resigns effective March 6, 2026; Deepak Ochani appointed CFO from April 1, 2026. Auditors issued unmodified review report.

Likely market impact

Revenue rebound is encouraging, but persistent losses, weak debt service coverage, and CFO transition may keep sentiment cautious near term.